IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MATTEELLI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.597
AS - Asia 4.732
EU - Europa 4.325
SA - Sud America 697
AF - Africa 130
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.530
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.507
SG - Singapore 1.581
CN - Cina 1.519
UA - Ucraina 1.414
HK - Hong Kong 970
IT - Italia 699
DE - Germania 662
BR - Brasile 648
TR - Turchia 349
FI - Finlandia 326
IE - Irlanda 316
GB - Regno Unito 313
RU - Federazione Russa 304
IN - India 119
FR - Francia 69
ZA - Sudafrica 68
CA - Canada 55
SE - Svezia 55
AT - Austria 40
PK - Pakistan 33
BE - Belgio 28
AU - Australia 24
BD - Bangladesh 24
MX - Messico 24
NL - Olanda 22
IQ - Iraq 20
SA - Arabia Saudita 19
NZ - Nuova Zelanda 18
AR - Argentina 15
ID - Indonesia 14
MY - Malesia 14
CZ - Repubblica Ceca 13
RO - Romania 12
PL - Polonia 11
KE - Kenya 10
MA - Marocco 10
ES - Italia 9
CO - Colombia 8
JP - Giappone 8
VN - Vietnam 8
EU - Europa 7
UZ - Uzbekistan 7
IR - Iran 6
MU - Mauritius 6
TZ - Tanzania 6
CL - Cile 5
PE - Perù 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 4
GH - Ghana 4
GY - Guiana 4
KH - Cambogia 4
PH - Filippine 4
PT - Portogallo 4
PY - Paraguay 4
AM - Armenia 3
AZ - Azerbaigian 3
CH - Svizzera 3
EC - Ecuador 3
EG - Egitto 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
UG - Uganda 3
VE - Venezuela 3
ZW - Zimbabwe 3
BB - Barbados 2
BG - Bulgaria 2
CR - Costa Rica 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
HN - Honduras 2
JM - Giamaica 2
JO - Giordania 2
LK - Sri Lanka 2
LS - Lesotho 2
NG - Nigeria 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
UY - Uruguay 2
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 24.523
Salva come PNG Salva come JPEG
Città #
Fairfield 2.323
Woodbridge 1.582
Houston 1.207
Singapore 1.083
Jacksonville 1.062
Ashburn 1.001
Hong Kong 955
Seattle 944
Wilmington 833
Cambridge 827
Chandler 760
Princeton 604
Ann Arbor 603
Beijing 421
Dublin 316
New York 315
Nanjing 302
Istanbul 295
Helsinki 197
Des Moines 150
Moscow 135
San Diego 135
Brescia 133
Dearborn 117
Nanchang 111
Shenyang 79
Changsha 76
Munich 71
Shanghai 68
Hebei 64
London 60
Nuremberg 56
Jinan 55
Jiaxing 54
Milan 54
Tianjin 53
Los Angeles 51
São Paulo 49
The Dalles 43
Kocaeli 35
Brussels 28
Rome 27
San Francisco 27
Hangzhou 26
Ningbo 25
Rio de Janeiro 25
Messina 24
Norwalk 24
Kunming 23
Verona 23
New Delhi 22
Turku 22
Belo Horizonte 20
Lanzhou 20
Boardman 18
Toronto 18
Chicago 17
Santa Clara 17
Lancaster 16
Palermo 16
Haikou 15
Mexico City 15
Romola 15
Vienna 15
Brasília 14
Cape Town 14
Zhengzhou 14
Falkenstein 13
Kilburn 13
Orange 13
Ottawa 12
Riyadh 12
Chiswick 11
Frankfurt am Main 11
Auckland 10
Central 10
Curitiba 10
Durban 10
Guangzhou 10
Leawood 10
Pretoria 10
Taiyuan 10
Brno 9
Fort Worth 9
Lappeenranta 9
Spalding 9
Taizhou 9
Atlanta 8
Bari 8
Changchun 8
Düsseldorf 8
Falls Church 8
Fortaleza 8
Fuzhou 8
Kuala Lumpur 8
Recife 8
Redwood City 8
Stockholm 8
Sydney 8
Warsaw 8
Totale 18.133
Salva come PNG Salva come JPEG
Nome #
Treatment of TB 348
WHO strategies for the programmatic management of drug-resistant tuberculosis 280
Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infection in adolescents in Northern Italy: an observational school-based study. 263
Treatment patterns and associated costs for genital warts in Italy 186
Impact of the SARS Coronavirus 2 epidemic on tuberculosis treatment outcome, Northern Italy 180
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 168
Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: Different methodology and settings, same results 164
Rediscovering high technology from the past: Thoracic surgery is back on track for multidrug-resistant tuberculosis 155
Towards tuberculosis elimination: An action framework for low-incidence countries 151
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae among high-school participants using the Versant CT/GC DNA 1.0 assay (kinetic PCR). 145
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 143
Imported malaria in an HIV-positive traveler. A case-report with a fatal outcome 141
Global tuberculosis prevention: Should we start from the beginning? 138
The cascade of care in diagnosis and treatment of latent tuberculosis infection: A systematic review and meta-analysis 133
Tuberculosis: epidemiology and control 132
Crossborder travel and multidrugresistant tuberculosis (MDRTB) in Europe 129
Chlamydia trachomatis genotypes in school adolescents, Italy 127
Active tuberculosis case finding among pregnant women: A pilot project in Burkina Faso 127
Advances in the treatment of malaria 126
STI epidemics in the Indian Ocean Region: can the phase be assessed? 125
Mycobacterium sherrisii pulmonary disease, Burkina Faso 123
Contact investigation based on serial interferon-gamma release assays (IGRA) in children from the hematology-oncology ward after exposure to a patient with pulmonary tuberculosis. 121
Latent Mycobacterium tuberculosis infection 120
Identification of the skin virome in a boy with widespread human papillomavirus-2-positive warts that completely regressed after administration of tetravalent human papillomavirus vaccine 119
Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis 119
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy 119
Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study 118
Louse-borne relapsing fever in a refugee from Mali 118
Latent tuberculous infection: Ethical considerations in formulating public health policy 117
Breaking the barriers: Migrants and tuberculosis 117
Differences in BCG vaccination and tuberculin skin-test positivity 115
Viral Load and Risk of Tuberculosis in HIV Infection 115
Comparison of effectiveness and safety of imipenem/clavulanate-versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB 115
Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting 115
Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy 114
Assessing the impact of defining a global priority research agenda to address HIV-associated tuberculosis 114
Tuberculosis elimination and the challenge of latent tuberculosis 114
Extensively drug-resistant tuberculosis: Epidemiology and management 114
Guidance for programmatic management of latent tuberculosis infection in the European Union/European Economic Area 114
Risk assessment of tuberculosis in immunocompromised patients: A TBNET study 113
New Antituberculosis Drugs: From Clinical Trial to Programmatic Use 113
The Holy Grail of prevention of sexually transmitted infections in travellers 113
Sentinel surveillance of imported dengue via travellers to Europe 2012 to 2014: Tropnet data from the denguetools research initiative 113
Baggage Malaria in Italy: Cryptic Malaria explained? 111
New italian guidelines for malaria prophylaxis in travellers to endemic areas 111
Changing antimicrobial resistance profiles among Neisseria gonorrhoeae isolates in Italy, 2003 to 2012 111
Building a European database to gather multi-country evidence on active and latent TB screening for migrants 111
Epidemiological features and case-management practices of imported malaria in northern Italy 110
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 110
Recrudescence of Plasmodium falciparum malaria in a primigravidae woman with anemia as the only sign of diseases: a case report 110
Travel-associated sexually transmitted infections: An observational cross-sectional study of the GeoSentinel surveillance database 109
In reply. Promoting ethical and evidence-based policies for latent tuberculosis 109
Nonnucleoside Reverse-transcriptase Inhibitor- vs Ritonavir-boosted Protease Inhibitor-based Regimens for Initial Treatment of HIV Infection: A Systematic Review and Metaanalysis of Randomized Trials 109
An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease 109
Prevalence of anti-poliovirus type 1, 2 and 3 antibodies in unvaccinated Italian travelers 108
Fatal disseminated toxoplasmosis during primary HIV infection. 108
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 107
Effectiveness and safety of meropenem/ clavulanate-containing regimens in the treatment of MDR- and XDR-TB 107
Advancing global programmatic management of latent tuberculosis infection for at risk populations 107
Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV 106
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy 106
Recommendations for the diagnosis of pediatric tuberculosis 105
A scoping review of cost-effectiveness of screening and treatment for latent tuberculosis infection in migrants from high-incidence countries 104
Imported malaria in northern italy: Epidemiology and clinical features observed over 18 years in the teaching hospital of Brescia 104
Recent developments in the diagnosis and management of tuberculosis 103
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report 103
Travel-associated sexually transmitted infections: an observational cross-sectional study of the GeoSentinel surveillance database 102
Recommendations Concerning the Therapeutic Approach to Immunocompromised Children with Tuberculosis 102
Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection 102
Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015 102
Respiratory syndrome and respiratory tract infections in foreign-born and national travelers hospitalized with fever in Italy 102
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 101
The Italian registry of pulmonary non-tuberculous mycobacteria - IRENE: The study protocol 101
Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual network. 100
Compassionate and optimum use of new tuberculosis drugs 100
Diabetes and tuberculosis: What else beyond? 100
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study 100
A Strange Manifestation of Malaria in a Native Nigerian Boy 100
Recommendations for treating children with drug-resistant tuberculosis 100
Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis 100
Prevalence and distribution of soil-transmitted helminth (STH) infections in urban and indigenous schoolchildren in Ortigueira, State of Paranà, Brasil: implications for control 99
Multiple-dose pharmacokinetics of efavirenz with and without the use of rifampicin in HIV-positive patients. 99
Exogenous reinfection of tuberculosis in a low-burden area 99
Molecular analysis of tetracycline-resistant gonococci: rapid detection of resistant genotypes using a real-time PCR assay 98
The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: A systematic review 98
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso 98
Disseminated Mycobacterium genavense infection after immunosuppressive therapy shows underlying new composite heterozygous mutations of β1 subunit of IL-12 receptor gene. 97
Ripped from the headlines: How can we harness communications to control TB? 97
Treatment optimization in patients co-infected with HIV and Mycobacterium tuberculosis infections: Focus on drug-drug interactions with rifamycins 96
Multidisciplinary approach to prostatitis 96
Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy 95
An epidemiological survey of vulvovaginal candidiasis in Italy 95
Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe 94
Implementation of tuberculosis prevention for exposed children, burkina faso 93
Tuberculosis elimination: where are we now? 93
Women facing HIV. Key question on women with HIV infection: Italian consensus workshop. 92
Cameroon's multidrugresistant tuberculosis treatment programme jeopardised by crossborder migration 92
Malaria after international travel: A GeoSentinel analysis, 2003-2016 92
App-based symptoms screening with Xpert MTB/RIF Ultra assay used for active tuberculosis detection in migrants at point of arrivals in Italy: The E-DETECT TB intervention analysis 92
gammadelta T lymphocytes in the peripheral blood of patients with tuberculosis with and without HIV co-infection. 91
Totale 11.830
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.110
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.110
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020269 0 0 0 0 0 0 0 0 0 0 0 269
2020/20215.353 61 376 1.140 752 357 446 99 492 434 597 337 262
2021/20222.126 110 423 59 110 13 129 133 181 101 244 178 445
2022/20232.179 346 47 24 211 175 578 1 222 358 18 91 108
2023/20242.088 124 64 110 144 80 387 74 89 575 26 43 372
2024/20254.898 40 22 54 551 691 480 372 153 501 467 1.115 452
Totale 25.005